Citations

Mayo Clinic

Showing 10 of 108522 citations.

Diminutive colorectal polyp resection comparing hot and cold snare and cold biopsy forceps polypectomy. Results of a pilot randomized, single-center study
Gómez, Victoria , Badillo, Raul, Krishna, Murli, Diehl, Nancy N. , Badillo, Raul J, Crook, Julia E. , Wallace, Michael B.

Endoscopy International Open | January 14, 2015 | Volume: 03 | Issue: 01 | Pages: C1-C1

10.1055/s-0034-1391366 | PMID 27547814 Get It

In‐vivo microscopy in the diagnosis of intestinal neoplasia and inflammatory conditions
Buchner, Anna M. , Wallace, Michael B. , Wallace, Michael B

Histopathology | January 14, 2015 | Volume: 66 | Issue: 1 | Pages: 137-146

10.1111/his.12597 | PMID 25639481 Get It

Confocal laser endomicroscopy (CLE) is a rapidly emerging tool in endoscopic imaging allowing in‐vivo microscopy of examined gastrointestinal mucosa. This review will discuss the most recent advances of confocal laser endomicroscopy in the diagnosis of intestinal neoplasia and inflammatory conditions.
Fibromyalgia Flares: A Qualitative Analysis
Vincent, Ann , Whipple, Mary O. , Rhudy, Lori M. , Whipple, Mary

Pain Medicine | January 14, 2015 | Volume: 17 | Issue: 3 | Pages: 463-468

10.1111/pme.12676 | PMID 25586303 Get It

Abstract Objective. Patients with fibromyalgia report periods of symptom exacerbation, colloquially referred to as “flares” and despite clinical observation of flares, no research has purposefully evaluated the presence and characteristics of flares in fibromyalgia. The purpose of this qualitative study was to describe fibromyalgia flares in a sample of patients with fibromyalgia. Methods. Using seven open-ended questions, patients were asked to describe how they perceived fibromyalgia flares and triggers and alleviating factors associated with flares. Patients were also asked to describe how a flare differs from their typical fibromyalgia symptoms and how they cope with fibromyalgia flares. Content analysis was used to analyze the text. Results. A total of 44 participants completed the survey. Responses to the seven open-ended questions revealed three main content areas: causes of flares, flare symptoms, and dealing with a flare. Participants identified stress, overdoing it, poor sleep, and weather changes as primary causes of flares. Symptoms characteristic of flares included flu-like body aches/exhaustion, pain, fatigue, and variety of other symptoms. Participants reported using medical treatments, rest, activity and stress avoidance, and waiting it out to cope with flares. Conclusions. Our results demonstrate that periods of symptom exacerbation (i.e., flares) are commonly experienced by patients with fibromyalgia and symptoms of flares can be differentiated from every day or typical symptoms of fibromyalgia. Our study is the first of its kind to qualitatively explore characteristics, causes, and management strategies of fibromyalgia flares. Future studies are needed to quantitatively characterize fibromyalgia flares and evaluate mechanisms of flares.
Association of the Colorectal CpG Island Methylator Phenotype with Molecular Features, Risk Factors, and Family History
Weisenberger, Daniel J. , Levine, A. Joan, Long, Tiffany I. , Buchanan, Daniel D. , Walters, Rhiannon, Rosty, Christophe , Joshi, Amit D. , Lindor, Noralane M. , Daftary, Darshana, Gallinger, Steven , Selander, Teresa, Bapat, Bharati , Ahnen, Dennis J. , Haile, Robert W. , Young, Joanne , Haile, Robert W. , Clendenning, Mark , Stern, Mariana Carla , Marchand, Loı̈c Le , Newcomb, Polly A. , Campbell, Peter T. , Casey, Graham , Baron, John A. , Hopper, John L. , Laird, Peter W. , Siegmund, Kimberly D. , Buchanan, Daniel D , Haile, Robert W , Rosty, Christophe

Cancer Epidemiology, Biomarkers & Prevention | January 13, 2015 | Volume: 24 | Issue: 3 | Pages: 512-519

10.1158/1055-9965.epi-14-1161 | PMID 25587051 Get It

Abstract Background: The CpG island methylator phenotype (CIMP) represents a subset of colorectal cancers characterized by widespread aberrant DNA hypermethylation at select CpG islands. The risk factors and environmental exposures contributing to etiologic heterogeneity between CIMP and non-CIMP tumors are not known. Methods: We measured the CIMP status of 3,119 primary population-based colorectal cancer tumors from the multinational Colon Cancer Family Registry. Etiologic heterogeneity was assessed by a case–case study comparing risk factor frequency of colorectal cancer cases with CIMP and non-CIMP tumors using logistic regression to estimate the case–case odds ratio (ccOR). Results: We found associations between tumor CIMP status and MSI-H (ccOR = 7.6), BRAF V600E mutation (ccOR = 59.8), proximal tumor site (ccOR = 9; all P < 0.0001), female sex [ccOR = 1.8; 95% confidence interval (CI), 1.5–2.1], older age (ccOR = 4.0 comparing over 70 years vs. under 50; 95% CI, 3.0–5.5), and family history of CRC (ccOR = 0.6; 95% CI, 0.5–0.7). While use of NSAIDs varied by tumor CIMP status for both males and females (P = 0.0001 and P = 0.02, respectively), use of multivitamin or calcium supplements did not. Only for female colorectal cancer was CIMP status associated with increased pack-years of smoking (Ptrend < 0.001) and body mass index (BMI; Ptrend = 0.03). Conclusions: The frequency of several colorectal cancer risk factors varied by CIMP status, and the associations of smoking and obesity with tumor subtype were evident only for females. Impact: Differences in the associations of a unique DNA methylation–based subgroup of colorectal cancer with important lifestyle and environmental exposures increase understanding of the molecular pathologic epidemiology of this heavily methylated subset of colorectal cancer. Cancer Epidemiol Biomarkers Prev; 24(3); 512–9. ©2015 AACR.
3D Reconstruction of the Left Ventricle From Four Echocardiographic Projections
Krishnan, Navaneetha, Song, Zeying, Hoffmann, Kenneth R., Bëlohlávek, Marek , McMahon, Eileen M. , Borazjani, Iman

Volume 1A: 34th Computers and Information in Engineering Conference | January 13, 2015 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1115/detc2014-34463 Get It

The left ventricle (LV) of a human heart receives oxygenated blood from the lungs and pumps it throughout the body via the aortic valve. Characterizing the LV geometry, its motion, and the ventricular flow is critical in assessing the heart’s health. An automated method has been developed in this work to generate a three-dimensional (3D) model of the LV from multiple-axis echocardiography (echo). Image data from three long-axis sections and a basal section is processed to compute spatial nodes on the LV surface. The generated surfaces are output in a standard format such that it can be imported into the curvilinear-immersed boundary (CURVIB) framework for numerical simulation of the flow inside the LV. The 3D LV model can be used for better understanding of the ventricular motion and the simulation framework provides a powerful tool for studying left ventricular flows on a patient specific basis. Future work would incorporate data from additional cross-sectional images.
Improving Efficiency in Clinical Trials Using Auxiliary Information: Application of a Multi-State Cure Model
Conlon, A. S. C. , Taylor, Jeremy M. G. , Sargent, Daniel J.

Biometrics | January 13, 2015 | Volume: 71 | Issue: 2 | Pages: 460-468

10.1111/biom.12281 | PMID 25585942 Get It

Summary In clinical trials, an intermediate marker measured after randomization can often provide early information about the treatment effect on the final outcome of interest. We explore the use of recurrence time as an auxiliary variable for estimating the treatment effect on overall survival in phase three randomized trials of colon cancer. A multi-state model with an incorporated cured fraction for recurrence is used to jointly model time to recurrence and time to death. We explore different ways in which the information about recurrence time and the assumptions in the model can lead to improved efficiency. Estimates of overall survival and disease-free survival can be derived directly from the model with efficiency gains obtained as compared to Kaplan–Meier estimates. Alternatively, efficiency gains can be achieved by using the model in a weaker way in a multiple imputation procedure, which imputes death times for censored subjects. By using the joint model, recurrence is used as an auxiliary variable in predicting survival times. We demonstrate the potential use of the proposed methods in shortening the length of a trial and reducing sample sizes.
Treating Proximal Tibial Growth Plate Injuries Using Poly(Lactic-co-Glycolic Acid) Scaffolds
Milbrandt, Todd A. , Puleo, David A. , Clark, Amanda M. , Hilt, J. Zach

BioResearch Open Access | January 13, 2015 | Volume: 4 | Issue: 1 | Pages: 65-74

10.1089/biores.2014.0034 | PMID 26309783 Get It

Flat epithelial atypia and risk of breast cancer: A Mayo cohort study
Said, Samar M. , Visscher, Daniel W., Nassar, Aziza , Frank, Ryan D. , Vierkant, Robert A. , Frost, Marlene H., Ghosh, Karthik, Hartmann, Lynn C. , Nassar, Aziza , Radisky, Derek C. , Degnim, Amy C. , Vierkant, Robert A

Cancer | January 13, 2015 | Volume: 121 | Issue: 10 | Pages: 1548-1555

10.1002/cncr.29243 | PMID 25639678 Get It

BACKGROUND Based on its cytologic features, and its co‐occurrence with atypical hyperplasia and breast cancer, flat epithelial atypia (FEA) has been proposed as a precursor lesion on the pathway to the development of breast cancer. It is often referred to as an “atypical” or high‐risk lesion. However, to the authors' knowledge, the long‐term risk of breast cancer in women with FEA is undefined. METHODS Specimens with FEA were identified among excisional breast biopsies in the Mayo Clinic Benign Breast Disease Cohort, which includes 11,591 women who had benign biopsy findings at the Mayo Clinic in Rochester, Minnesota between 1967 and 2001. Breast cancer risk among subsets of patients with FEA and nonproliferative, proliferative, and atypical hyperplasia (AH) was assessed using standardized incidence ratios (SIRs) compared with the Iowa Surveillance, Epidemiology, and End Results registry. RESULTS FEA was identified in 282 women (2.4%); 130 had associated AH (46%) and 152 (54%) were classified as having proliferative disease without atypia (PDWA). With median follow‐up of 16.8 years, the SIR for breast cancer in patients with AH plus FEA was 4.74 (95% confidence interval [95% CI], 3.17‐6.81) versus 4.23 (95% CI, 3.44‐5.13) for those with AH without FEA ( P = .59). The SIR for patients with PDWA plus FEA was 2.04 (95% CI, 1.23‐3.19) versus 1.90 (95% CI, 1.72‐2.09) for patients with PDWA without FEA ( P = .76). CONCLUSIONS FEA is an uncommon finding in women with benign breast disease. FEA does not appear to convey an independent risk of breast cancer beyond that of the associated PDWA or AH. Cancer 2015;121:1548–1555 . © 2015 American Cancer Society .
Ultrasound-Guided Fine-Needle Aspiration Biopsy of Thyroid Nodules in Patients Taking Novel Oral Anticoagulants
Lyle, Melissa , Dean, Diana S., Lyle, Melissa A.

Thyroid | January 13, 2015 | Volume: 25 | Issue: 4 | Pages: 373-376

10.1089/thy.2014.0307 | PMID 25584817 Get It

Pericardial Effusion Following Drain Removal after Percutaneous Epicardial Access for an Electrophysiology Procedure
Killu, Ammar M. , Wan, Siu‐Hin , Munger, Thomas M. , Hodge, David O. , Mulpuru, Siva K. , Packer, Douglas L. , Asirvatham, Samuel J. , Friedman, Paul A. , Asirvatham, Samuel J

Pacing and Clinical Electrophysiology | January 13, 2015 | Volume: 38 | Issue: 3 | Pages: 383-390

10.1111/pace.12565 | PMID 25583074 Get It

ObjectivesTo determine the frequency and predictors of pericardial effusion following epicardial sheath removal.BackgroundPericardial effusion can occur following cardiac surgical or interventional procedures including percutaneous epicardial access (EpiAcc), which is increasingly used as part of electrophysiology ablation procedures.MethodsA retrospective analysis of the Mayo Clinic comprehensive electronic medical record was performed from all patients who underwent planned EpiAcc as part of an electrophysiology ablation procedure between January 1, 2004 and June 30, 2013.ResultsOf 144 patients (mean age 51.3 ± 15.5 years, 68% male) who underwent planned EpiAcc as part of an electrophysiology ablation (95.8% pericardial access success rate), seven (4.9%) developed a postoperative pericardial effusion requiring repeat EpiAcc. Inferior access was utilized in 74 (51.4%) patients. Patients with pericardial effusion tended to be younger (41.1 years vs 51.8 years, P = 0.08) and were more likely to have undergone inferior approach access (85.7% vs 49.6%, P = 0.06) than those who did not develop postoperative pericardial effusion. Seventy‐one percent of patients with postoperative pericardial effusion versus 32.1% of patients without postoperative pericardial effusion had a preprocedure ejection fraction ≥55% (P = 0.03). There were no procedural‐related deaths, and no difference in mortality between groups.ConclusionsPostoperative pericardial effusion requiring repeat access/drainage was relatively infrequent, occurring in 4.9% of patients shortly after epicardial procedures. While the majority occur early and therefore require close observation, some patients may present in a delayed manner.